History and Clinical Uses
The alkyl nitrites (e.g., amyl, butyl, isopropyl) are colorless or yellow liquids at room temperature and are highly volatile. They are esters of nitrous acid that have a fruity odor (often described as unpleasant) and have been nicknamed "poppers" because of the sound made when glass capsules containing amyl nitrite are crushed (12) .
The vasodilatory effect following inhalation of amyl nitrite vapor was described in 1859 and led to the first report of its clinical application to provide relief for angina pectoris in 1867 (13, 14) . In the 1880s, butyl nitrites were found to have similar vasodilatory qualities, but these compounds were never developed for clinical use (12) .
Amyl nitrite was initially marketed as a prescription drug in the United States in 1937 and remained a prescription drug until September 1960, when the Food and Drug Administration (FDA) eliminated the prescription requirement. In the 1960s, nitroglycerin sublingual tablets, dermally applied ointments, and, later, transdermal patches began to replace amyl nitrite as the preferred treatment for angina pectoris. In the late 1960s, pharmacists and drug manufacturers noticed widespread purchases of amyl nitrite by apparently healthy young men. These over-the-counter purchases became the impetus for the FDA to reinstate the prescription requirement in 1968. Since then an underground market for amyl nitrite has emerged (15) . For the last few years, there has been no medical advertising for pharmaceutical-grade amyl nitrite, and it is no longer listed in the Physician's Desk Reference (16) .
Amyl nitrite remains available by prescription. The clinical indication listed in the package insert is angina pectoris (17) . Amyl nitrite is used experimentally to treat cyanide poisoning. The drug produces methemoglobin, which has a high affinity for cyanide, and leads to the production of cyanomethemoglobin, releasing cyanide from cell mitochondrial cytochrome oxidase sites, where it is otherwise destructive (18) .
When amyl nitrite became difficult to procure for nonmedical or recreational purposes during the 1970s, there was a proliferation of butyl nitrite products by nonpharmaceutical manufacturers (15) . Butyl nitrites were marketed as "liquid incense" or "room odorizers." Because the labels on bottles containing butyl nitrites stated that they were not to be inhaled and no health claim was made, the FDA never had jurisdiction over this product as it does medicine and many foods.
The legal status of some key nitrite preparations has changed in the past few years. One development prompting this change has been the description of several acute and chronic adverse effects attributed to the abuse of nitrite inhalants (15) . In response to those reports, the U.S. Congress enacted a ban on the manufacture and retail sale of butyl nitrites (except when used in specified chemical commercial processes) in the Anti-Drug Abuse Act of 1988 (Public Law 100-690, Section 2404). The 
inhalant use and nitrite use than females. The proportion of males who used nitrites at least once was typically twice the percentage of females reporting lifetime use (20) . The highest rate of nitrite use reported by high school seniors in 1979 was in the Northeast, and the lowest rate was reported in the West. Rates have decreased markedly in all regions, with the highest rates in 1992 reported in the NorthCentral United States and the lowest rates in the Northeast (21) .
Nitrite use varies by race/ethnicity as well as geographic area. Although racial/ethnic data are not available for high school seniors, the Public Health Servicesponsored National Household Survey provides limited population-based estimates. Self-reported nitrite use in 1991 was highest for white males in each of six selected metropolitan areas for which data were analyzable. National estimates of use by females was 1.3% for white females in 1991, 0.7% for black females, and 0.8% for Hispanic females (22) .
Nitrite use has been commonly reported among homosexual men for several decades, but less so for self-identified heterosexual adolescents and adults. (34) found that nitrite inhalant use was the most strongly associated with HIV seropositivity among a cohort of 1045 gay men.
Nitrites and the Immune System. The hypothesis that nitrite inhalants might induce immune suppression was first advanced by Goedert et al. in 1982 (8) . Tlymphocyte abnormalities were reported in 9 of 10 gay men who reported regular nitrite use compared to 1 of 7 who did not use nitrites (8) . This study came under criticism because of its small numbers and lack of evaluation for many potentially confounding variables, including HIV infection.
Several other investigators have evaluated the effects of nitrites on human immune function. Hersh et al. (35) cultured venous blood with up to 1% isobutyl nitrite in alcohol and, after 24 hr, observed irreversible effects on various lymphocyte functions, including blastogenesis, cellmediated cytotoxicity, and monocyte adherence. Dax et al. (36) at the Addiction Research Center studied the effects of three inhalations at various concentrations per day for 3 or 18 days on the immune systems of 18 male volunteers. One inhalation of amyl nitrite (0.18, 0.36, or 0.48 ml) was administered from a closed 4-1 flask at 3-hr intervals each day of study. After full exhalation, the subject inhaled from the flask through the mouthpiece with the nose "clipped" and held at full inspiration for 5 sec before exhalation. Blood was drawn for immune profile immediately after the last inhalation and 1, 4, and 7 days later. Modest depression of T-lymphocyte counts and natural killer cell activity were noted with a rebound to at least baseline levels several days after the last inhalations. Cell proliferation responses to phytohemagglutinin (PHA), concanavalin A (Con A), and pokeweed mitogen (PWM) were unaffected by amyl nitrite inhalation (36) .
Ross and Drew (37) interviewed 97 gay men in Australia and measured T-cell counts and mitogenesis responses to PHA, Con A, and PWM. T-lymphocyte counts did not differ between nitrite users and nonusers. Mitogenesis in response to the three antigens was significantly higher in users compared with nonusers after cells were incubated for 72 hr, but the differences disappeared for PHA and Con A by 96 hr (37) .
Studies of the immune system of mice following nitrite challenge are even less consistent than those among humans. Studies evaluating nitrites' effects on immune parameters have been hampered because formulations and dosages vary greatly, and routes of administration and immunologic outcome measures have not been standardized.
CDC investigators evaluated the effects of isobutyl nitrite on the immune system of BALB/c mice (38, 39) . The mice were exposed to either 50 or 300 ppm isobutyl nitrite for 6.5 hr/day, 5 days/week for up to 18 weeks. Mice were sacrificed at various times and antibody-producing cells were enumerated; mitogenesis responses were evaluated to PHA, Con A, PWM, and lipopolysaccharide and skin test reactions to purified protein derivative of immunized mice were observed. No immunotoxic effects were discerned, although decreased thymic weights were noted for female mice at the highest dose levels (38, 39) .
Other investigators have noted decreases in natural killer cell activity, helper lymphocyte counts, and/or body weight in mice exposed to nitrites. Lotzova et al. (40) injected mice with 0.50 ml isobutyl nitrite and noted significant depression of natural killer cell activity in female C57BL/6 x DBA/2 mice. Administration of isobutyl nitrite by inhalation (2-to 3-min exposures twice daily) also suppressed natural killer cell function in mice (40) .
Ortiz and Rivera (41) exposed CD-I mice to increasing amounts of amyl nitrite by nasal administration for up to 21 weeks. The total T-cell and suppressor cell counts did not differ from mice exposed to saline solutions. However, helper cell counts, body weight, and weight gain rates were significantly decreased in nitrite-exposed versus control mice (41 (50) . These observations suggested that some cofactor highly associated with gay lifestyle was operating in conjunction with HIV in the pathogenesis of AIDS-related KS. Nitrite inhalants were suggested as one possible factor (10, 11, (51) (52) (53) (54) (55) (56) .
There are several reasons to consider nitrite inhalants as a KS cofactor. First, the epidemiology of nitrite use in the United States parallels that of HIV-related KS. Nitrite inhalants are used more commonly by gay men than others (6); use has been declining since AIDS was first reported (30) and has roughly paralleled the pattern of reported KS cases, and use among whites is greater than among blacks, as is the incidence of KS (22) . Second, some, but not all, epidemiologic studies have shown a statistical association between the development of KS among gay men with AIDS and the use of large quantities of nitrite inhalants when compared with gay men with AIDS, but without KS (11, (51) (52) (53) (54) (55) (56) . Third, anecdotal reports of increased frequency of AIDS-related KS on the chest and face, especially the nose, and in the lungs are consistent with the body areas most heavily exposed to nitrite vapors when inhaled. Finally, plausible mechanisms of action have been proposed for nitrites and their metabolites, such as cholesteryl nitrite and nitrosamines, to be carcinogenic, and mutagenesis has been demonstrated in the Ames test (7, 57, 58) . Nitrites are known to affect small blood vessels, the anatomic site presumed to give rise to KS (12 gay men with KS as well as women and others with KS should be encouraged. Animal models exposed to retroviruses and nitrite inhalants should be pursued.
The possible links of nitrites with AIDS and the other known adverse effects of these inhaled substances suggest that more attention to these products by clinicians and researchers is warranted. Clinicians and community leaders should discourage the use of nitrite inhalants. Researchers should study further the associations between nitrite use and HIV infection and AIDS.
